# Trinity™ BIOLOX Delta™ CoC THR Multi-center Study

> **NCT01921309** · NA · UNKNOWN · sponsor: **Corin** · enrollment: 342 (actual)

## Conditions studied

- Osteoarthritis
- Avascular Necrosis
- Rheumatoid Arthritis
- CDH

## Interventions

- **DEVICE:** Trinity CoC Total Hip System
- **DEVICE:** Trinity Ceramic-on-Poly THR

## Key facts

- **NCT ID:** NCT01921309
- **Lead sponsor:** Corin
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2021-09
- **Final completion:** 2021-12
- **Target enrollment:** 342 (ACTUAL)
- **Last updated:** 2021-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01921309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01921309, "Trinity™ BIOLOX Delta™ CoC THR Multi-center Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01921309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*